-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

203.O1.6 203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Know Thy(mus) Self, Know Thy Enemy: From Lymphocyte Genetic Variation to Disease

Symposia: Lymphocytes and Acquired or Congenital Immunodeficiency Disorders Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Viral, Autoimmune disorders, Bleeding and Clotting, Translational Research, Genetic Disorders, Genomics, Bioinformatics, Clinical Research, Diseases, Immune Disorders, Immunodeficiency, Immune mechanism, Thrombocytopenias, Infectious Diseases, Immunology, White blood cell disorders, Lymphoid Malignancies, Biological Processes, Myeloid Malignancies, Technology and Procedures, Profiling, Pathogenesis
Saturday, December 7, 2024: 12:00 PM-1:30 PM
Room 11 (San Diego Convention Center)
Moderators:
Andres Chang, MD, PhD, Emory University and Chuanfeng Wu, MD, Ph.D, National Institutes of Health
Disclosures:
Chang: AstraZeneca: Consultancy, Honoraria.
12:00 PM

Kameron Allen Kooshesh, MD, BA1,2,3,4, Brody Foy, DPhil5, Richard Baylis, MD, PhD6*, Karin Gustafsson, PhD1,2,3,4*, Daniel Zlotoff, MD, PhD7*, Tomas Neilan, MD7* and David Scadden, MD1,2,3,4

1Harvard Stem Cell Institute, Cambridge, MA
2Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA
3Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA
4Harvard Medical School, Boston, MA
5Department of Laboratory Medicine & Pathology, University of Washington, Seattle, WA
6Division of Cardiology, University of California San Francisco, San Francisco, CA
7Division of Cardiology, Massachusetts General Hospital, Boston, MA

12:15 PM

Benjamin J Schmiedel, PhD1, Zubin Roy1*, Vicente Fajardo Rosas1*, Cristian Gonzalez-Colin1*, Job Rocha1* and Pandurangan Vijayanand, MD, PhD2*

1La Jolla Institute for Immunology, La Jolla, CA
2La Jolla Institute For Immunology, La Jolla, CA

12:30 PM

Rushil Shah, BS1*, Konstantinos Aliazis, PhD2*, Leda Xanthi Katopodi, MS3*, Anthos A Christofides, MD, PhD1*, Halil-Ibrahim Aksoylar, PhD4*, Dimitra Karagkouni, PhD5,6*, Rinku Pal, BS7*, Lequn Li, MD, PhD8*, Nikolaos Patsoukis, PhD7*, Ioannis S Vlachos, PhD3,6,9*, Pankaj Seth, PhD10* and Vassiliki A Boussiotis, MD, PhD11

1Beth Israel Deaconess Medical Center, Harvard Medical School, BOSTON, MA
2Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Brookline, MA
3Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA
4Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, BOSTON, MA
5Department of Pathology, Cancer Research Institute, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA
6Broad Institute of Harvard and MIT, Cambridge, MA
7Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
8Beth Isreal Deaconess Medical Center, Boston, MA
9Beth Israel Deaconess Medical Center, Boston, MA
10Janssen Research & Development, Spring House, PA
11Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, MA

12:45 PM

Lipei Shao, PhD1*, Aaron Boothby, MD2, S. Lawrence Bailey, BS3*, Aastha Chauhan4*, Martin Boechenek5*, Terry B. Gernsheimer, MD6, John W. Semple, PhD7, James L. Zehnder, MD8, V. Koneti Rao, MD9, Jin Ping, PhD1*, David F. Stroncek, MD, MS10, Moritz Stolla, MD11 and Sandya R. Panch, MD, MPH12

1Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD
2University of Washington/Fred Hutchinson Cancer Center, Saint Paul, MN
3Bloodworks NW, Seattle, WA
4Bloodworks NW Research Institute, Seattle, WA
5BloodWorks NW, Seattle, WA
6University of Washington and Fred Hutchinson Cancer Center, Seattle, WA
7Division of Hematology and Transfusion Medicine, Lund University, Lund, Sweden
8Department of Pathology, Stanford University, Stanford, CA
9NIAID National Institutes of Health, Bethesda, MD
10Center for Cellular Engineering, National Institutes of Health Clinical Center, Bethesda, MD
11Bloodworks and University of Washington, Seattle, WA
12Fred Hutchinson Cancer Center, Seattle, WA

1:00 PM

Xinyue Deng1,2*, Qiang Gao1,2*, Kefeng Shen1,2*, Wei Mu1,2*, Tong Ge, MD, PhD1,2*, Jiachen Wang, MD, PhD1,2*, Jianfeng Zhou, MD, PhD1,2*, Yicheng Zhang1,2*, Dengju Li, PhD1,2 and Min Xiao, MD, PhD1,2*

1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Department of Scientific Research Management, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

1:15 PM

Yujing Zou, PhD1*, Jonathan Bardahl, DO2*, Yiqun Jiao1*, James Yang2*, Danika Dai2*, Alexandra Wolfarth3*, Danielle Borgonia4*, Byung Ha Lee, PhD3* and Benny J. Chen, MD5

1Duke University, Durham, NC
2Duke University, Durham
3NeoImmuneTech, Inc, Rockville, MD
4NeoImmuneTech, Rockville, MD
5Duke Univ. Medical Center, Durham, NC

*signifies non-member of ASH